Status:
COMPLETED
Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer
Lead Sponsor:
Legacy Health System
Conditions:
Breast Cancer
Joint Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT). Another purpose of the study is to fin...
Detailed Description
Post-menopausal women currently on AIT for breast cancer treatment who self-report musculoskeletal side effects related to AIT to their physicians.
Eligibility Criteria
Inclusion
- Post Menopausal - evidenced by no menses for the past 6 months or FSH level \>40
- Patient complaints of musculoskeletal symptoms
- Currently taking AIT for ER positive postmenopausal breast cancer
Exclusion
- Previously taken Blue Citrus
- Presence of bone metastasis
- Unable to complete VAS Pain Scale
- Unable to comply/complete SF 12 Quality of Life survey
- Plan to discontinue AIT in less then six months
- Unable to complete ADL scale
- Have diagnosis of fibromyalgia
- Have diagnosis of rheumatoid arthritis
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00702858
Start Date
April 1 2008
End Date
June 1 2011
Last Update
August 28 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.